Abstract
Coagulation Profile In COVID-19
Highlights
The novel Corona virus disease is an infectious respiratory tract infection which has affected more than 166 million patients globally
Out of 101 COVID-19 positive patients, 93(92.1%) patients were in the survivor group and 08 (7.8%) patients were in the non-survivor group
This study infers that high D-dimers and prolonged Activated Partial Thromboplastin Time (APTT) are associated with mortality in COVID-19 Patients
Summary
The novel Corona virus disease is an infectious respiratory tract infection which has affected more than 166 million patients globally. Association of COVID-19 disease with other body systems is well established. COVID-19 infections are found to be associated with variable degrees of coagulopathy and severe cases show a higher incidence of COVID-19 associated coagulopathy that may increase the morbidity and mortality [1]. Severe COVID-19 illness is associated with robust inflammation, which leads to hypercoagulable state. The underlying pathophysiology leading to hypercoagulable state has not been clearly understood. COVID-19 involves respiratory system and affects other systems of the body. The association of coagulation dysfunction with disease progression of COVID-19 is proven by much research. The main objective of our study is to evaluate the association of coagulation profile with mortality
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
